| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it will shortly begin shipping Famotidine 10 mg tablets through an agreement with Teva Pharmaceutical Industries Ltd. The terms of the...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced an agreement to purchase Wrafton Laboratories Ltd., a subsidiary of McBride plc (LONDON: MCB) for $44 million. Wrafton Laboratories is a supplier...
-
May 18, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its presentation scheduled for Wednesday, May 23, 2001 at 8 a.m. EDT at the UBS Warburg Global Specialty Pharmaceuticals Conference in New...
-
May 1, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months ended March 31, 2001. Net sales for the quarter were $192.0 million, an increase of four percent...
-
Apr 25, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2001 third quarter ended March 31, 2001, on Tuesday, May 1, 2001 at approximately 8:30 a.m....
-
Feb 15, 2001
The Perrigo Company (NASDAQ: PRGO) today announced a new addition to the Company's management team: Matthew E. Morris as Senior Vice President and Chief Information Officer. Mr. Morris brings to...
-
Feb 7, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that C. Ted Borgel, a pharmaceutical industry veteran of more than 35 years, has been named Vice President of Quality and Compliance. In this...
-
Jan 23, 2001
The Perrigo Company's (NASDAQ: PRGO) second quarter results announced today included a $24.0 million charge, or $0.21 per share, for the voluntary discontinuation of production and withdrawal of...
-
Nov 13, 2000
The Perrigo Company (NASDAQ: PRGO) today announced that its Board of Directors has authorized the repurchase of up to $20 million of the Company's common stock from time-to-time over the next 18...
-
Nov 8, 2000
The Perrigo Company (NASDAQ: PRGO), the nation's largest manufacturer of over-the-counter (OTC) and nutritional products for the store brand market, today announced that in response to...
-
Oct 25, 2000
The Perrigo Company (NASDAQ: PRGO) today announced results for the first quarter of fiscal year 2001 ended September 30, 2000. On a proforma basis, which reflects the ongoing over-the-counter...
-
Oct 23, 2000
In conjunction with Perrigo Company's (NASDAQ: PRGO) first quarter earnings release, you are invited to listen to its conference call that will be broadcast over the Internet on Wednesday, October...
-
Aug 16, 2000
The Perrigo Company (NASDAQ: PRGO) today reported results for the fiscal year and fourth quarter ended July 1, 2000. On a proforma basis, which reflects only the ongoing over-the-counter (OTC)...